MedPath

Establishment of therapeutic strategy for renal cell carcinoma based on the evaluation by FDG PET/CT

Phase 2
Recruiting
Conditions
advanced renal cell carcinoma
Registration Number
JPRN-UMIN000008141
Lead Sponsor
Yokohama City University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

patients who have serious illness in heart, lung, liver, or kidney

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The association of the evaluation by FDG PET/CT and progression-free survival and overall survival
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath